HIGH GRADE GLIOMA OF CENTRAL NERVOUS SYSTEM: SINGLE CENTER TREATMENT EXPERIENCE
Objective: To evaluate characteristics and treatment responses of patients with high grade gliomas (HGG) in our center. Medical files of patients with malignant CNS tumors between 1987-2020 were analyzed retrospectively. There were 44 patients with HGG. Case report: Diagnosis of patients as follows:...
Main Authors: | Nur OLGUN, Deniz KIZMAZOGLU, Dilek INCE, Emre CECEN, Şefika AKYOL, Ayşe ONAL, Batuhan OZDOGAR, Ceren KIZMAZOGLU, Ayşe DEMIRAL, Rıza CETINGOZ, Handan UCAR, Erdener OZER |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137921012402 |
Similar Items
-
Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
by: Nur Olgun, et al.
Published: (2022-12-01) -
Infantile Hemangiomas of the Head and Neck: A Single-Center Experience
by: Deniz Kizmazoglu, et al.
Published: (2024-03-01) -
Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies
by: Tekincan Aktas, et al.
Published: (2023-08-01) -
The Significance of Histopathologic Assessment in Bone Marrow Disease in Neuroblastoma
by: Sumeyye EKMEKCI, et al.
Published: (2022-05-01) -
Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients
by: Burçin Baran, et al.
Published: (2023-09-01)